(Q71766929)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8912472%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

review article

1 reference

title

Molecular biology of prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8912472%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

0 references

1 reference

X B Shi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8912472%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

P H Gumerlock

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8912472%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

R W deVere White

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8912472%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

publication date

1 January 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8912472%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

published in

World Journal of Urology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8912472%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8912472%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8912472%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

318-328

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8912472%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00184605

21 October 2019

exact match

0 references

cites work

Allelic loss of the retinoblastoma gene in primary human prostatic adenocarcinomas.

1 reference

12 December 2020

Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone

1 reference

12 December 2020

Suppression of Bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor alpha, and ceramide

1 reference

12 December 2020

Overexpression of Her-2/neu may be an indicator of poor prognosis in prostate cancer

1 reference

12 December 2020

Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers.

1 reference

12 December 2020

Expression of E-cadherin in primary and metastatic prostate cancer.

1 reference

12 December 2020

High levels of nm23 expression are related to cell proliferation in human prostate cancer

1 reference

12 December 2020

Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence

1 reference

12 December 2020

BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death

1 reference

12 December 2020

Oncogenes in prostate cancer. An update

1 reference

12 December 2020

ras gene mutations in human prostate cancer

1 reference

12 December 2020

Molecular biologic aspects of human prostatic carcinoma

1 reference

12 December 2020

Transforming growth factor-beta 1 overproduction in prostate cancer: effects on growth in vivo and in vitro

1 reference

12 December 2020

Retinoblastoma gene mutations in primary human prostate cancer.

1 reference

12 December 2020

Enhanced expression of the c-myc protooncogene in high-grade human prostate cancers

1 reference

12 December 2020

The p53 tumour suppressor gene

1 reference

12 December 2020

Frequency and characterization of p53 mutations in clinically localized prostate cancer

1 reference

12 December 2020

Tumor suppressor gene p53 mutations in human prostate cancer

1 reference

12 December 2020

Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13

1 reference

12 December 2020

WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis

1 reference

12 December 2020

NM23 gene expression in human prostatic carcinomas and benign prostatic hyperplasias: altered expression in combined androgen blockaded carcinomas

1 reference

12 December 2020

Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer

1 reference

12 December 2020

TP53 mutations in prostatic cancer. Analysis of pre- and post-treatment archival formalin-fixed tumour tissue

1 reference

12 December 2020

Hormonal regulation of transforming growth factor beta-2 expression in human prostate cancer

1 reference

12 December 2020

Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers

1 reference

12 December 2020

Mutant p53 expression in prostate carcinoma

1 reference

12 December 2020

Immunohistochemical determination of p53 protein nuclear accumulation in prostatic adenocarcinoma

1 reference

12 December 2020

Molecular biology of prostate cancer

1 reference

12 December 2020

Somatic mutations of the WAF1/CIP1 gene in primary prostate cancer

1 reference

12 December 2020

Partial growth suppression of human prostate cancer cells by the Krev-1 suppressor gene

1 reference

12 December 2020

Loss of chromosome arm 8p loci in prostate cancer: Mapping by quantitative allelic imbalance

1 reference

12 December 2020

Tumor suppressor genes in prostatic oncogenesis.

1 reference

12 December 2020

Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene.

1 reference

12 December 2020

The frequency of apoptosis correlates with the prognosis of Gleason Grade 3 adenocarcinoma of the prostate

1 reference

12 December 2020

Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis

1 reference

12 December 2020

Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer

1 reference

12 December 2020

P53 and Ki-67 immunoreactivity in human prostate cancer and benign hyperplasia

1 reference

12 December 2020

Expression of the c-erbB-2 (HER-2/neu) oncoprotein in human prostatic carcinoma

1 reference

12 December 2020

p53 mutations occur in clinical, but not latent, human prostate carcinoma.

1 reference

12 December 2020

Genetic alterations in prostate adenocarcinoma.

1 reference

12 December 2020

p53 protein accumulation and gene mutation in the progression of human prostate carcinoma

1 reference

12 December 2020

Frequency and characterization of p53 mutations in primary and metastatic human prostate cancer.

1 reference

12 December 2020

Genetic Alterations in Prostate Cancer

1 reference

12 December 2020

Association of transforming growth factor-beta 1 with prostate cancer: an immunohistochemical study

1 reference

12 December 2020

Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas

1 reference

12 December 2020

Increased bcl-2 protein levels in prostatic adenocarcinomas are not associated with rearrangements in the 2.8 kb major breakpoint region or with p53 protein accumulation

1 reference

12 December 2020

Expression of bcl-2 and the progression of human and rodent prostatic cancers

1 reference

12 December 2020

Mutation of the MXI1 gene in prostate cancer

1 reference

12 December 2020

Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis.

1 reference

12 December 2020

Association of p53 mutations with metastatic prostate cancer.

1 reference

12 December 2020

Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer

1 reference

12 December 2020

Loss of heterozygosity from the short arm of chromosome 8 is an early event in breast cancers

1 reference

12 December 2020

Activated Ki-ras oncogene in human prostatic adenocarcinoma

1 reference

12 December 2020

Frequency of homozygous deletion at p16/CDKN2 in primary human tumours

1 reference

12 December 2020

p53 mutations in human cancers

1 reference

12 December 2020

Homozygous deletions at 8p22 and 8p21 in prostate cancer implicate these regions as the sites for candidate tumor suppressor genes

1 reference

12 December 2020

Androgen receptor content of prostate carcinoma cells estimated by immunohistochemistry is related to prognosis of patients with stage D2 prostate carcinoma

1 reference

12 December 2020

Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma.

1 reference

12 December 2020

Infrequent RAS oncogene mutations in human prostate cancer

1 reference

12 December 2020

Genetic alterations in the adenoma--carcinoma sequence

1 reference

12 December 2020

Androgen receptor gene mutations in human prostate cancer

1 reference

12 December 2020

Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31.1

1 reference

12 December 2020

Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display

1 reference

12 December 2020

Bcl-2 and the regulation of programmed cell death

1 reference

12 December 2020

p53 oncogene mutations in human prostate cancer specimens

1 reference

12 December 2020

Steroid-growth factor interaction in human prostate cancer. 1. Short-term effects of transforming growth factors on growth of human prostate cancer cells

1 reference

12 December 2020

Hereditary aspects of prostate cancer.

1 reference

12 December 2020

Activated ras alleles in human carcinoma of the prostate are rare.

1 reference

12 December 2020

Localization of potential tumor suppressor loci to a < 2 Mb region on chromosome 17q in human prostate cancer

1 reference

12 December 2020

A genetic model for colorectal tumorigenesis

1 reference

12 December 2020

Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia

1 reference

12 December 2020

Glutathione S-transferases, structure, regulation, and therapeutic implications

1 reference

12 December 2020

1 reference

12 December 2020

p53 in prostate cancer: frequent expressed transition mutations

1 reference

12 December 2020

E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas

1 reference

12 December 2020

Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression

1 reference

12 December 2020

[Androgen receptor gene mutations and p53 gene analysis in advanced prostate cancer]

1 reference

12 December 2020

Small Subgroup of Aggressive, Highly Proliferative Prostatic Carcinomas Defined by p53 Accumulation

1 reference

12 December 2020

Molecular and cellular changes associated with the acquisition of metastatic ability by prostatic cancer cells

1 reference

12 December 2020

Alteration of the Tumor Suppressor Gene p53 in a High Fraction of Hormone Refractory Prostate Cancer

1 reference

12 December 2020

Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer

1 reference

12 December 2020

Transforming growth factor beta 2 (TGF-beta 2) levels in plasma of patients with metastatic breast cancer treated with tamoxifen

1 reference

12 December 2020

Localization of metastasis suppressor gene(s) for prostatic cancer to the short arm of human chromosome 11

1 reference

12 December 2020

Allelic loss of chromosomes 16q and 10q in human prostate cancer

1 reference

12 December 2020

Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer

1 reference

12 December 2020

Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma

1 reference

12 December 2020

Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles

1 reference

12 December 2020

Nuclear localization of androgen receptor in heterogeneous samples of normal, hyperplastic and neoplastic human prostate

1 reference

12 December 2020

Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma

1 reference

12 December 2020

Expression of c-erb B-2/neu proto-oncogene in human prostatic cancer tissues and cell lines

1 reference

12 December 2020

Genomic methylation patterns of the Dunning R-3327 prostate adenocarcinoma system

1 reference

12 December 2020

Androgen receptor gene mutations in human prostate cancer

1 reference

12 December 2020

p53 is mutated in a subset of advanced-stage prostate cancers

1 reference

12 December 2020

Growth factors and oncogenes in prostate cancer

1 reference

12 December 2020

Molecular biology of prostate cancer progression.

1 reference

12 December 2020

Apoptosis and the prostate

1 reference

12 December 2020

Growth factors in urologic tissues: detection, characterization, and clinical applications

1 reference

12 December 2020

Alterations of the retinoblastoma gene in clinically localized, stage B prostate adenocarcinomas

1 reference

12 December 2020

Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer

1 reference

12 December 2020

Mutational analysis of CDKN2 (CDK4I/MTS1) gene in tissues and cell lines of human prostate cancer

1 reference

12 December 2020

Expression of transforming growth factor-alpha and the epidermal growth factor receptor in human prostate tissues

1 reference

12 December 2020

KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2

1 reference

12 December 2020

Analysis of retinoblastoma (RB) gene deletion in human prostatic carcinomas

1 reference

12 December 2020

Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers

1 reference

12 December 2020

Cancer statistics, 1996.

1 reference

12 December 2020

Transcriptional regulation of the human E-cadherin gene in human prostate cancer cell lines: characterization of the human E-cadherin gene promoter

1 reference

12 December 2020

Allelic loss in locally metastatic, multisampled prostate cancer

1 reference

12 December 2020

Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer

1 reference

12 December 2020

Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis

1 reference

12 December 2020

c-met proto-oncogene expression in benign and malignant human prostate tissues

1 reference

12 December 2020

Androgens regulate proliferation of human prostate cancer cells in culture by increasing transforming growth factor-alpha (TGF-alpha) and epidermal growth factor (EGF)/TGF-alpha receptor

1 reference

12 December 2020

Basic research in prostate cancer: molecular biology.

1 reference

12 December 2020

Metastasis suppressor genes.

1 reference

12 December 2020

P53 mutations and loss of heterozygosity on chromosomes 8p, 16q, 17p, and 18q are confined to advanced prostate cancer

1 reference

12 December 2020

Quantitation of NM23 expression in human prostate tissues

1 reference

12 December 2020

The multistep nature of cancer

1 reference

12 December 2020

p53 gene alterations in human prostate carcinoma

1 reference

12 December 2020

Alterations of the retinoblastoma gene in human prostate adenocarcinoma

1 reference

12 December 2020

Immunohistochemical detection of p53 protein as a prognostic indicator in prostate cancer

1 reference

12 December 2020

Induction of transforming growth factor beta in hormonally treated human prostate cancer

1 reference

12 December 2020

Genetic alterations in localized prostate cancer: Identification of a common region of deletion on chromosome arm 18q

1 reference

12 December 2020

Prevalence of androgen receptor gene mutations in latent prostatic carcinomas from Japanese men

1 reference

12 December 2020

Heterogeneity in intratumor distribution of p53 mutations in human prostate cancer

1 reference

12 December 2020

Chromosomal abnormalities and related events in prostate cancer

1 reference

12 December 2020

Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells

1 reference

12 December 2020

K-ras activation and ras p21 expression in latent prostatic carcinoma in Japanese men

1 reference

12 December 2020

Contribution of HER-2/neu oncogene expression to tumor grade and DNA content analysis in the prediction of prostatic carcinoma metastasis

1 reference

12 December 2020

A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens

1 reference

12 December 2020

Endocrine control of prostate cancer.

1 reference

12 December 2020

Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer

1 reference

12 December 2020

Infrequent involvement of p53 gene mutations in the tumourigenesis of Japanese prostate cancer

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00184605

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8912472%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference